Treatment of Acute Contrast Reactions

Reaction Recognition - Spotting Trouble Fast

Acute Contrast Reactions (ACRs) are adverse events occurring shortly after intravascular contrast administration.

• Types of ACRs:
  • Chemotoxic: Dose-dependent, direct organ toxicity (e.g., nephropathy).
  • Idiosyncratic/Allergic-like: Unpredictable, not dose-dependent (e.g., urticaria, anaphylaxis).
• Timing: Most reactions are immediate, typically within 1 hour; severe ones often within 5-20 minutes.

Severity Classification:

• Mild: Self-limiting (e.g., limited urticaria, nausea, transient flushing).
• Moderate: Requires medical intervention (e.g., diffuse urticaria, mild bronchospasm, transient hypotension).
• Severe: Life-threatening (e.g., laryngeal edema, severe bronchospasm, shock, arrhythmias, convulsions).

⭐ Most severe contrast reactions occur within the first 5-20 minutes after contrast administration.

First Response - The Initial Game Plan

⭐ The absolute first step in managing an acute contrast reaction is to STOP the contrast media infusion immediately.

📌 Remember 'STOP & SUPPORT': Stop contrast, Tell for help (Code Blue), Oxygen, Position, Support vitals.

Key Actions:

• STOP contrast.
• Call for Help (Code Blue).
• Initiate ABCDE assessment.
• Administer Oxygen (e.g., 6-10 L/min if needed).
• Continuously Monitor Vitals (HR, BP, SpO2, RR).

Mild Mayhem - Handling Hiccups

• Symptoms: Often include:
  • Limited urticaria/pruritus.
  • Mild nausea/vomiting.
  • Transient flushing, warmth, or chills.
  • Headache, dizziness, or anxiety.
  • Altered taste.
• Treatment: Management focuses on:
  • Observation and reassurance.
  • Antihistamines: e.g., Diphenhydramine 25-50 mg IM/IV/PO.
  • Antiemetics: e.g., Ondansetron 4-8 mg IV.

⭐ Most mild reactions are self-limiting and resolve with symptomatic treatment or observation alone; epinephrine is not indicated.

Moderate Muddle - Stepping Up Care

Key symptoms indicating a need for more intensive management:

• Diffuse urticaria/erythema
• Facial/laryngeal edema (without dyspnea)
• Mild bronchospasm/wheezing
• Vasovagal reaction: hypotension and/or bradycardia

Pharmacological interventions:

• Antihistamines: IV Diphenhydramine 25-50 mg
• H2 blockers: Ranitidine 50 mg IV
• Inhaled β-agonists: Salbutamol MDI/nebulizer 2.5-5 mg
• Corticosteroids (delayed action): Hydrocortisone 100-200 mg IV
• Hypotension: IV fluids
• Persistent vasovagal bradycardia: Atropine 0.5-1 mg IV

⭐ For vasovagal reactions, initial management includes leg elevation and IV fluids; atropine is used if bradycardia is significant and symptomatic.

Severe Storm - Anaphylaxis Action

• Symptoms: Severe bronchospasm/respiratory distress, laryngeal edema (stridor/hoarseness), severe hypotension/shock, arrhythmias, loss of consciousness, seizures.
• Immediate Management: 📌 Anaphylaxis: 'EPI IM NOW!' (Epinephrine Intramuscular is Number One Worldwide)
  • Epinephrine IM: 0.3-0.5 mg (1:1000) anterolateral thigh. Repeat q 5-15 min.
  • High-flow Oxygen: 10-15 L/min.
  • IV access, Normal Saline bolus.
• If Unresponsive/Circulatory Collapse:
  • Epinephrine IV: 0.1 mg (1:10,000) slow push over 1 min, or infusion.
• Adjuncts:
  • IV Corticosteroids: Hydrocortisone 200 mg or Methylprednisolone 40-80 mg.
  • IV Antihistamines (H1+H2 blockers).
  • Glucagon (if on beta-blockers).

⭐ The cornerstone of anaphylaxis management is early administration of intramuscular epinephrine into the anterolateral thigh.

High‑Yield Points - ⚡ Biggest Takeaways

• Mild reactions: Managed with observation and antihistamines.
• Moderate reactions: Require antihistamines, bronchodilators; epinephrine if progressing.
• Severe/Anaphylaxis: Epinephrine (IM/IV) is life-saving. Prioritize ABCDE (Airway, Breathing, Circulation).
• Epinephrine dose (anaphylaxis): 0.3-0.5 mg IM (1:1000 solution). Repeat as needed.
• Corticosteroids: Administer to prevent biphasic or protracted reactions, not for immediate relief.
• Bronchospasm: Treat with inhaled beta-2 agonists (e.g., salbutamol).
• Hypotension: Manage with IV fluids and Trendelenburg; atropine for vasovagal reactions_._